Preparation of a vaccine (illustration).

-

Keith Birmingham / AP / SIPA

US pharmaceutical giant Pfizer plans to seek emergency authorization for its Covid-19 vaccine from US authorities in the third week of November, its CEO announced on Friday.

“Let me be clear, assuming the data is positive, Pfizer will apply for emergency use authorization in the United States shortly after the safety milestone has been passed, during the third week of November, ”said Albert Bourla in an open letter posted on social networks.

… /… More information to come on

20 Minutes

World

Facebook bans ads discouraging getting vaccinated

World

World Bank releases $ 12 billion for vaccines

  • Health

  • Laboratory

  • Covid 19

  • Vaccine

  • Coronavirus